A clinical trial being conducted at the University of Kentucky is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.
Only four months ago, we marked the 50th anniversary of the 1963 March on Washington, that seminal moment when the eyes of the nation focused on 250,000 demonstrators in Washington, D.C., and where Dr. Martin Luther King, Jr., delivered his immortal “I Have a Dream” speech.
On Nov. 7, the Harbor House honored their volunteers, staff members, sponsors and donors at their Annual Appreciation Awards. Harbor House of Louisville is a non-profit certified training and development center for adults with developmental and physical disabilities, including brain injuries. Photos By BILL WINE | Contributing Photographer
In another sign of the University of Kentucky’s emergence as one of the top universities in America, a new national ranking has UK among the top producers of U.S. Fulbright Scholars — one of the highest honors a faculty member can receive.
The Sullivan University System Promotes Davisson to Chief Operating Officer The Sullivan University System (SUS) has announced the promotion of Thomas F. Davisson to senior vice president and chief operating officer. Davisson has more than 42 years of experience in the education field and has been with SUS for the past 25 years, most recently [...]
With the support of an innovative research model, a clinic devoted to individualized intervention approaches for children with autism spectrum disorder (ASD) has been making huge impacts in the lives of Central Kentucky children and their families.